| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 10/15/2008 | CN100425616C Method for extracting breviscapine from fresh erigeron breviscapus |
| 10/14/2008 | US7435805 O-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
| 10/09/2008 | WO2008119543A1 Polymorph of clarithromycin (form v) |
| 10/09/2008 | WO2008032105A3 Flavonoid derivatives and their uses |
| 10/09/2008 | US20080249060 Nucleoside derivatives for treating hepatitis c virus infection |
| 10/09/2008 | US20080249035 exhibits a characteristic X-ray diffraction pattern; dissolving clarithromycin in a ketone; precipitation is carried out by cooling |
| 10/09/2008 | US20080249033 Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections |
| 10/09/2008 | US20080248105 Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| 10/09/2008 | DE102007016367A1 Polymorph von Clarithromycin (Form V) Polymorph of clarithromycin (Form V) |
| 10/08/2008 | EP1976860A2 Processes for the preparation of azithromycin |
| 10/08/2008 | EP1976859A1 CRYSTALLINE FORM OF 1´-(1-METHYLETHYL)- 4´-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5´-METHYL-1H-PYRAZOL-3´-O-beta-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 10/08/2008 | EP1976536A2 Boron-containing small molecules |
| 10/08/2008 | CN101282985A Cell surface coating with hyaluronic acid oligomer derivative |
| 10/08/2008 | CN101279993A 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof |
| 10/08/2008 | CN101279964A Guaiane type sesquiterpenes, preparation and medical use thereof |
| 10/08/2008 | CN100424090C Extraction technology of avermectin |
| 10/08/2008 | CN100424089C Method for preparing macrolides half-synthesized antibiotics telithromycin |
| 10/07/2008 | CA2384572C Pesticidal macrolides |
| 10/02/2008 | WO2008019240A3 3, 6-bridged tylosin derivatives |
| 10/01/2008 | EP1973924A1 Amorphous telithromycin compound |
| 10/01/2008 | CN100422201C Arylation method for the functionalization of O-allyl erythromycin derivatives |
| 10/01/2008 | CN100422200C Epimedin C contrast preparation method and its product |
| 10/01/2008 | CN100422199C Extractive from specific part of skullcap, preparation method and application |
| 09/30/2008 | US7429568 Antidiabetic agents; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; hyperglycemia, obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole |
| 09/30/2008 | CA2382480C Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 09/25/2008 | WO2008019784A3 Avermectin derivatives |
| 09/25/2008 | US20080234211 Decladinosyl-Macrolides With Anti-Inflammatory Activity |
| 09/25/2008 | US20080234210 Anti-Fungal Composition |
| 09/24/2008 | EP1971864A2 Kit comprising 2,4-dichlorophenoxyacetic acd derivatives and antibodies for highly sensitive detection assays |
| 09/24/2008 | CN101270140A Common camellia flavone glycosides B with estrogen liveness, preparation method and application thereof |
| 09/24/2008 | CN101270139A Common camellia flavone glycosides A with estrogen liveness, preparation method and application thereof |
| 09/24/2008 | CN101270108A Method for preparing liposoluble tea polyphenol |
| 09/24/2008 | CN101270105A Coumarin compound for enzymatic activity analysis and enzyme inhibitor sifting motion, and synthesizing process |
| 09/23/2008 | CA2483875C 6,11 bicyclic erythromycin derivatives |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2362253C Avermectin derivatives |
| 09/18/2008 | CA2680527A1 Erythromycin-based macrolides |
| 09/17/2008 | CN101265283A Method for extracting hesperidin and naringin |
| 09/17/2008 | CN101265282A Method for separating catalpol from fresh rehmanniae root |
| 09/17/2008 | CN100418979C Method of extracting sisomicin using cation exchange resin |
| 09/17/2008 | CN100418978C Process for preparing sisomicin using film separation technology |
| 09/17/2008 | CN100418977C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 09/16/2008 | US7425547 Nucleoside derivatives for treating hepatitis C virus infection |
| 09/12/2008 | WO2008011588A3 Glycoconjugates of phosphoramidate alkylators for treatment of cancer |
| 09/11/2008 | US20080221158 Novel 14 and 15 Membered Ring Compounds |
| 09/11/2008 | US20080221046 Macrolides With Anti-Inflammatory Activity |
| 09/11/2008 | US20080221045 Hepatic Function-Improving Agent |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | CN101260134A Precipitation method for vancomycin |
| 09/10/2008 | CN101260133A Method for preparing hyperoside and isoquercetin from cotton petal |
| 09/10/2008 | CN101260132A Method for preparing high-purity rutoside monomer and rutoside standard sample |
| 09/10/2008 | CN101260131A Method for extracting iridoid active site and monomer from eucommia bark |
| 09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/09/2008 | US7423133 Fluorescent glycosides and methods for their use |
| 09/09/2008 | US7422877 Activatable recombinant neurotoxins |
| 09/04/2008 | WO2008106226A2 Macrolide compounds and methods of making and using the same |
| 09/04/2008 | WO2008106224A1 Macrolide compounds and methods of making and using the same |
| 09/04/2008 | WO2008028050A3 Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1963350A1 Biologically active compounds |
| 09/03/2008 | EP1963349A1 Novel loganin analogues and a process for the preparation thereof |
| 09/03/2008 | CN101255154A Substituted 2-indoline ketone derivatives as well as preparation method and uses thereof |
| 09/03/2008 | CN101255151A High-performance fat-soluble antioxidant fat-soluble tea-polyphenol and preparation method thereof |
| 09/03/2008 | CN100415764C Addition salts of azithromycin and citric acid and process for preparing them |
| 09/03/2008 | CN100415760C Swertiamarin monomer separation and purification method |
| 09/03/2008 | CN100415732C Kudzuvine flower isoflavone, monomer tectoridin and tectorigenin extraction method and uses |
| 09/02/2008 | US7419962 Semisynthetic trimethylenedioxy-erythromycin derivatives and their use in treating bacterial infections and cystic fibrosis; preparation |
| 09/02/2008 | US7419961 9a-azalides with anti-inflammatory activity |
| 09/02/2008 | US7419958 Antagonists that bind CD1d and inhibit activation of CD1d-restricted natural killer (NK) T cells, agents that block CD1d-specific receptors and CD1d decoys and a carrier or diluent; contact dermatitis for example |
| 09/02/2008 | US7419657 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines |
| 09/02/2008 | CA2282666C Novel erythromycin derivatives, method of preparation and application as medicines |
| 08/28/2008 | US20080207882 Method for producing thiophene glycoside derivatives |
| 08/28/2008 | US20080207770 Compositions enriched in phenolic compounds and methods for producing the same |
| 08/28/2008 | US20080207557 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 08/28/2008 | US20080207536 Erythromycin-11,12-carbamate derivatives; Grampositive, Gramnegative or anaerobic bacteria; Staphylococcus, Streptococcus, Enterococcus, Hemophilus, Moraxella, Chlamydia, Mycoplasma, Legionella, Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Baccillus or Enterobactericeae |
| 08/28/2008 | US20080207534 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
| 08/28/2008 | US20080206221 Nicotinamide Riboside Kinase Compositions and Methods for Using the Same |
| 08/27/2008 | EP1960414A2 Method for demethylating the 3'-dimethylamino group of erythromycin compounds |
| 08/27/2008 | EP1960413A2 Macrolides derivatives as antibacterial agents |
| 08/27/2008 | EP1960412A2 Amphotericin b salt |
| 08/27/2008 | EP0649429B1 Heteroatomic oligonucleoside linkages |
| 08/27/2008 | CN101250207A Canton love-pea vine total flavone c-glycosides effective part, preparation method and use thereof |
| 08/27/2008 | CN101250206A Effective part containing cyaniding 3-O-glucoside as well as preparation method and use thereof |
| 08/27/2008 | CN101250205A Catalpol and use of its derivatives in preparation of medicine controlling cerebrovascular disease |
| 08/27/2008 | CN100413879C Process for preparing 4''-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 08/27/2008 | CN100413878C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/27/2008 | CN100413512C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 08/26/2008 | US7417031 Induction apoptosis; oxidation resistance; preservatives |
| 08/26/2008 | CA2312021C Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 08/21/2008 | WO2008099368A1 Macrolide derivatives as antibacterial agents |
| 08/21/2008 | US20080200659 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 08/21/2008 | US20080200404 Therapeutic, prophylactic treatment of drug-resistant malarial strain; resistant to chloroquine, mefloquine, halofantrine, artemisinin, atovaquone/proguanil, doxycycline, primaquine |
| 08/21/2008 | US20080199414 Tiliroside or derivative; drugs, foods; ultraviolet radiation filters; aging and oxidation resistance; free radical scavengers; antiinflammatory, anticarcinogenic, and antiallergen agents; plant extracts; topically applied |
| 08/21/2008 | DE102007007644A1 New aminocoumarin compounds, designated novclobiocins, useful as broad-spectrum antibiotics and cytotoxic agents, prepared sing genetically modified bacterial strains |
| 08/20/2008 | EP1957508A2 Ketolide derivatives as antibacterial agents |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | CN101245087A Neoflavone glycoside compound in sweetening chrysanthemum and separation identification method |
| 08/20/2008 | CN100411617C Use of flavone compounds in preparing medicament |